Background: The b-3 adrenergic receptor gene (ADRB3) is part of the adrenergic system, which is known to play a key role in energy metabolism. The association between the Trp64Arg variant in the ADRB3 and body mass index (BMI) has been widely examined, but previous studies have been small and results have been inconsistent. Methods: We assessed the association between the ADRB3 Trp64Arg variant and BMI in a large UK population-based cohort of 4854 middle-aged men and women. We also performed a meta-analysis of 97 studies, involving 44 833 individuals, to place our findings in context. Results: Although we found no significant difference in BMI (0.20 kg/m 2 , P ¼ 0.40) between the Trp64Trp homozygotes and Arg64 allele carriers in our UK population-based cohort, the meta-analysis showed significant association between the Arg64Trp variant and BMI, with Arg64-allele carriers having a 0.24 kg/m 2 (P ¼ 0.0002) higher BMI compared with noncarriers. However, we also found substantial heterogeneity among the studies (P ¼ 2.2 Â 10 À14 ). The difference in East Asians (0.31 kg/m 2 , P ¼ 0.001) was 3.9 times larger than that in Europeans in whom no significant association was observed (0.08 kg/m 2 , P ¼ 0.36). This was consistent with the chronological cumulative decrease in the effect size, which decreased steadily in Europeans and reached nonsignificance after 11 studies in 1996. In East Asians, the cumulative effect size decreased after the first reports, but reached a steady state at a significant effect size of 0.24 kg/m 2 in 2000. Although the funnel plot indicated no apparent publication bias, smaller studies tended to report greater differences in BMI, compared with larger studies. Conclusions: Collectively, these data suggest that the Trp64Arg ADRB3 genetic variant might be associated with BMI in East Asians, but not Europeans. More generally, our study shows the importance of meta-analyses in the field of genetic association studies for common traits. Each genetic variant makes only a small contribution to variation in BMI, and large sample sizes are needed to reliably assess and interpret gene-phenotype associations.
Introduction
The adrenergic system plays a key role in regulating energy balance through the stimulation of both thermogenesis and lipid mobilization in adipose tissue. Polymorphisms in the adrenergic receptor genes (ADRs) have been extensively studied for association with obesity-related phenotypes. 1 The ADRB3 Trp64Arg polymorphism, a missense mutation in the first transmembrane domain of the b3-adrenergic receptor, has been the subject of considerable attention since it was first reported in 1995 when the New England Journal of Medicine published three studies [2] [3] [4] that showed weak but significant associations between the Trp64Arg variant and the onset of type 2 diabetes, insulin resistance and weight gain in the Pima Indian, 2 French 3 and Finnish populations. 4 Three subsequent meta-analyses on the association between the Trp64Arg polymorphism and body mass index (BMI) were published with inconsistent conclusions. [5] [6] [7] In the first meta-analysis, Allison et al. 5 pooled data from 23 studies published before June 1997 including a total of 7399 individuals of different ethnicities. No significant association was found, and the absence of effect heterogeneity suggested that the results were not affected by ethnicity or diabetes status. 5 Fujisawa et al. 6 reported on a second meta-analysis including eight additional studies published before January 1998 (a total of 31 studies and 9236 individuals). In contrast to the previous meta-analysis, Fujisawa et al., 6 observed a small but significant effect of the Trp64Arg polymorphism on BMI, with a higher BMI for the Arg64-carriers compared to those individuals who were Trp64Trp homozygotes (mean difference ¼ 0.30 kg/m 2 , 95% confidence interval (CI): 0.13-0.47). As in the previous meta-analysis, there was no evidence for effect heterogeneity by ethnicity. A third meta-analysis, restricted to studies of Japanese populations only (n ¼ 6582 individuals), reported a small but significant mean difference in BMI of 0.26 kg/m 2 (Po0.01), indicating that the presence of the Arg64 allele was associated with increased BMI. 7 Since the publication of the original meta-analyses, further studies have been conducted, and to date over 100 studies have reported on the relationship between the ADRB3 Trp64Arg polymorphism and BMI. Collectively, observational studies have reported conflicting associations and, importantly, the relevance of this variant to BMI remains uncertain.
We therefore assessed the association between the ADRB3 Trp64Arg polymorphism and BMI in a large populationbased cohort of 4854 middle-aged men and women of European descent. To help clarify the association between this variant and BMI, we also did an updated systematic review and meta-analysis, including data on 97 studies with 44 833 individuals.
Participants and methods

Study population
The study population is an ethnically homogeneous European population from the Norfolk cohort of the European Prospective Investigation into Cancer (EPIC). EPIC-Norfolk is an ongoing prospective cohort study of chronic diseases comprising approximately 25 000 Norfolk residents aged 45-75 who were recruited from general practice registers between 1993 and 1997 for a first health examination. 8 From January 1998, the cohort was invited for a second health examination and 15 786 people had attended by October 2000. The study population of 5000 individuals was randomly selected from the 15 786 people who had attended both health examinations. Participants were free of disease (cancer, coronary heart disease and diabetes) at baseline, and had height and weight measured during both clinical assessments. Only baseline data were included in the current analyses. BMI was calculated as weight (kg)/height 2 (Table 1 ).
Statistical analysis
We tested for Hardy-Weinberg equilibrium using a likelihood ratio test. On the basis of previous reports and comparability, we used a dominant genetic model for the primary analysis, comparing common homozygotes (Trp64Trp) with carriers of the Arg64-allele (Trp64Arg or 
Systematic review
Population-based case-control and cohort studies of adult participants published before May 2007, in which the ADRB3 gene Trp64Arg polymorphism had been related to BMI, were identified by electronic searches of PubMed, scanning of relevant reference lists, and by correspondence with authors of studies. We used the following key words: ADRB, ADRB3, ADR, and Trp64Arg. We only included studies in which mean BMI and standard deviation or standard error by genotype were available. When information was reported for more than one sub-population within a study (for example, obese versus nonobese; type 2 diabetes versus no diabetes), each sub-population was considered separately. Where intervention studies were identified, we used pre-intervention baseline data. If studies included samples that had been reported before, we verified with the authors to avoid including duplicate data. Studies were excluded if no response was received from the authors.
Some studies had been included in an earlier meta-analysis by Allison et al. 5 Of these studies, where the data we required did not appear in the original publication, we used the results presented in Allison's meta-analysis.
Meta-analysis
To calculate a pooled estimate of the relation between genotype and BMI, we used fixed (metan) and random (metan, random) effects models. Heterogeneity among studies was assessed using the Q and I 2 statistics. Information was collected on pre-specified study-level covariates to explore possible sources of heterogeneity (metareg): ethnicity, diabetes status, study size, BMI category (o25.0, 25.0-29.9, X30.0) and study design (population based on selected individuals). Ethnic group was defined as European, East Asian or other, as reported genotype frequencies vary substantially between these populations. Cumulative meta-analysis (metacum) was used to describe the chronological change over time. Funnel plots and the Egger test (metabias, graph(begg)) were used to assess evidence of possible publication bias.
Results
In our study of British Europeans, full BMI and genotype data were available for 4854 participants. We found no significant association between the ADRB3 Trp64Arg polymorphism and BMI ( Figure 1) . To examine possible sources of heterogeneity, we analysed the data stratified by pre-specified study-level covariates: ethnicity, diabetes status, study size, BMI category and study design (Figure 2) .
The difference in mean BMI between Trp64Trp and Arg64-allele carriers in East Asians (0.31 kg/m 2 , 95% CI 0.13-0.48, P ¼ 0.001) was greater than that in European populations in whom no significant association was observed (0.08 kg/m 2 , 95% CI À0.09 to 0.24, P ¼ 0.36). Although there was no statistically significant heterogeneity between East Asians and Europeans (P ¼ 0.22), the difference in minor allele frequency (18% in East Asians and 7.5% in Europeans) and in mean BMI warrants population stratification. The cumulative decrease in effect size over time reflects the difference between European and East Asian populations (Supplementary Figure 2 ). One year after the initial studies, 3, 4 which reported large differences between Arg64-allele carriers and Trp64Trp homozygotes, the cumulative effect size decreased steadily in Europeans and reached nonsignificance after 11 studies in 1996. 21 In East Asian populations, the cumulative effect size decreased after the first reports, but reached a steady state at a significant effect size of 0.24 kg/m 2 in 2000. 53 In addition to ethnicity, when we considered other studylevel covariates, we found that there was a tendency for smaller studies (no100) to report larger differences (mean difference: 0.40 kg/m 2 95% CI 0.07-0.73, P ¼ 0.017) when compared with bigger studies (n4500) (0.11 kg/m 2 , 95% CI À0.02 to 0.23, P ¼ 0.095). When stratified by study design and BMI categories, studies of non-selected populations were found to show smaller differences (0.10 kg/m 2 , 95% CI 0.00-0.21, P ¼ 0.051) than those based on selected populations , 95% CI 0.01-0.25, P ¼ 0.029). Compared with nondiabetes controls, studies of type 2 diabetes showed smaller differences in BMI by genotype. These trends suggest that the overall estimate may be biased and an overestimation of any true association, although none of the study-level covariables materially explained the heterogeneity among studies.
Discussion
In this paper, we have reported on the largest individual population-based study including 4854 individuals of European descent, showing no significant association between the ADRB3 Trp64Arg variant and BMI. Despite the large sample size, our study only had sufficient power (80%) to detect significant (a ¼ 0. The nearly fourfold difference in effect size and difference in Arg64-allele frequency suggest that the Trp64Arg polymorphism might be more important in East Asians than in Caucasians. A difference of 0.31 kg/m , as observed in East Asians, equals a difference of 790 g to 1 kg in absolute weight for a person with a height of 1.60-1.80 m, respectively. With an Arg64-allele frequency of B18%, 32.7% of the East Asian populations carry this variant and are thus at risk of a slightly higher BMI. In contrast, only 14.5% of Europeans carry the Arg64-allele (MAF B7.5%), and the observed effect size (0.08 kg/m 2 ) equals a difference of only 200-260 g for a person of 1.60-1.80 m height. However, this assumes that the association in Caucasians is 'true', which would require a sample size of 165 000 individuals (power ¼ 80%) to prove at a significance level of 5%. Ethnic heterogeneity was also
Study Ethnicity
Caucasian n =53; 23, 198 East Asian n =90; 16, 061 Other n =29; 5, 574 Overall test for hetrogeneity between subgroups: P =0.125
Overall test for hetrogeneity between subgroups: P =0.933 Overall test for hetrogeneity between subgroups: P =0.004
Difference in
Overall test for hetrogeneity between subgroups: P =0.120
Overall test for hetrogeneity between subgroups: P =0.003
Study Size The chronological cumulative effect size, which is the combined effect size of all studies published up to a particular year, indicates that one could have made these observations 12 years ago. Supplementary Figure 2 suggests that the initial publications that reported large effect sizes prompted many to investigate the ADRB3 Trp64Arg-BMI association in their populations. However, most studies that followed could not replicate the initial results such that the cumulative effect size came down quickly and reached nonsignificance for Europeans in 1996, after 11 publications. Nevertheless, many more studies were published and are indeed still being published. Similarly, for East Asians the cumulative effect size came down quickly, but reached a significant steady state in 2000 at a cumulative BMI difference of B0.24 kg/m 2 . While these previous reports indicate that there may be ethnic-specific differences in the magnitude of the association between this variant and BMI, our data and updated meta-analysis on 44 833 individuals show that the association between Trp64Arg genotype and BMI was statistically significant in East Asians but not in Europeans, although the difference between these two groups did not attain statistical significance. Nevertheless, we observed a difference in the cumulative plots for Europeans and East Asians. Collectively, these ethnic differences could be interpreted in a number of ways. First, the lack of association among Caucasians could be true, or it might simply be a reflection of the rarity of the minor allele in these populations, thus making it difficult to detect a true difference without using even larger studies. Second, the association we observed in East Asians may likewise be true; or, given that the cumulative effect size did not move to a null, it is possible to speculate that the association is open to bias from a perpetuation of multiple small studies or from selective reporting. This reinforces the need for fewer larger-scale studies to reliably confirm or refute gene-disease associations. Third, if the associations we observed in both populations were true, this would reflect real differences in disease risk.
Publication bias is a common problem in meta-analyses and generally leads to an overestimation of the effect size. However, the symmetrical funnel plot (Supplementary Figure 1) indicates that the average difference in mean BMI does not systematically increase with its standard error and, thus, there is no apparent publication bias. This is consistent with previous meta-analyses on the Trp64Arg variant. Although none of our study-level covariables importantly explained study heterogeneity, we found trends that were suggestive of bias in the overall summary estimate of the association between this genetic variant and BMI. Specifically, larger studies, studies on unselected populations, and those based on populations with lower BMIs tended on average to report smaller associations.
Our study clearly shows the importance of meta-analyses in the field of genetic association studies for common traits. Each genetic variant makes only a small contribution to variation in BMI, and large sample sizes are needed to prove that the associations are significant. However, if too large sample sizes are needed, because of small effect size or rare variants, one needs to question the clinical relevance of the variant. We also show that the observations we made in this paper could have been made earlier if meta-analyses had been carried out in 2000. Studies published over the last 7 years did not change the effect size or significance of the association.
